Extending use of existing Alzheimer's drug could delay move into nursing home

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Newly-released follow-up analysis from a 2012 clinical trial led by a

Updated on: February 26,2024

Extending use of existing Alzheimer's drug could delay move into nursing home

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Newly-released follow-up analysis from a 2012 clinical trial led by a

Updated on:February 26,2024

Research study validates neuroreader for accurate and fast measurement of brain volumes

by IOS PressDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A new neuroimaging software, Neuroreader, was shown to be as accurate as traditional met

Updated on: February 26,2024

Research study validates neuroreader for accurate and fast measurement of brain volumes

by IOS PressDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A new neuroimaging software, Neuroreader, was shown to be as accurate as traditional met

Updated on:February 26,2024

Degrading modified proteins could treat Alzheimer's, other 'undruggable' diseases

by American Chemical SocietyGraphical abstract. Credit:ACS Central Science(2023). DOI: 10.1021/acscentsci.2c01369Certain diseases, including Alzheimer's, are currently considered

Updated on: June 24,2024

Degrading modified proteins could treat Alzheimer's, other 'undruggable' diseases

by American Chemical SocietyGraphical abstract. Credit:ACS Central Science(2023). DOI: 10.1021/acscentsci.2c01369Certain diseases, including Alzheimer's, are currently considered

Updated on:June 24,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on: February 28,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on:February 28,2024

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2

Updated on: March 02,2024

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2

Updated on:March 02,2024

The freedom to roam for people with dementia

by Andrew Gould,University of PlymouthIan Sherriff, centre, with members of the Dartmoor Search and Rescue Team Plymouth, at a recent trial of the technology on DartmoorThe debilitating effect o

Updated on: February 27,2024

The freedom to roam for people with dementia

by Andrew Gould,University of PlymouthIan Sherriff, centre, with members of the Dartmoor Search and Rescue Team Plymouth, at a recent trial of the technology on DartmoorThe debilitating effect o

Updated on:February 27,2024

Antibiotics and antifungals may slightly affect Parkinson's risk, study finds

byRutgers UniversityEngineering p14endo15 proteolipid vehicles (FAST-PLVs). Credit:Parkinsonism & Related Disorders(2024). DOI: 10.1016/j.parkreldis.2024.107081A Rutgers Health s

Updated on: November 07,2024

Antibiotics and antifungals may slightly affect Parkinson's risk, study finds

byRutgers UniversityEngineering p14endo15 proteolipid vehicles (FAST-PLVs). Credit:Parkinsonism & Related Disorders(2024). DOI: 10.1016/j.parkreldis.2024.107081A Rutgers Health s

Updated on:November 07,2024

Alzheimer's disease: have we got the cause all wrong?

by Vicky Jones,The ConversationCredit: Unsplash/CC0 Public DomainEarly in the 20th century,Alois Alzheimerfirst described a disorder of progressive memory loss and confusion in a 50-

Updated on: April 10,2024

Alzheimer's disease: have we got the cause all wrong?

by Vicky Jones,The ConversationCredit: Unsplash/CC0 Public DomainEarly in the 20th century,Alois Alzheimerfirst described a disorder of progressive memory loss and confusion in a 50-

Updated on:April 10,2024

Scientists discover new receptor for nerve growth factor—a promising target for treating pain

byNew York UniversityNerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Credit: Bunnett LabResearchers at the NYU Pain

Updated on: December 19,2024

Scientists discover new receptor for nerve growth factor—a promising target for treating pain

byNew York UniversityNerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Credit: Bunnett LabResearchers at the NYU Pain

Updated on:December 19,2024

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

by University of California, Los AngelesResearchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encep

Updated on: April 01,2024

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

by University of California, Los AngelesResearchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encep

Updated on:April 01,2024

Reimagining preclinical trials: Marmosets as model systems for the study of Alzheimer's disease

by University of PittsburghMarmoset models bridge the current translation gap between human studies and cell and rodent models of AD. Establishment of marmoset models of aging and genetic risk lo

Updated on: March 02,2024

Reimagining preclinical trials: Marmosets as model systems for the study of Alzheimer's disease

by University of PittsburghMarmoset models bridge the current translation gap between human studies and cell and rodent models of AD. Establishment of marmoset models of aging and genetic risk lo

Updated on:March 02,2024

Brain shows changes in regions associated with anxiety after quitting alcohol, finds study

byResearch Society on AlcoholismGroup × anxiety and group × sex interactions in BNST functional connectivity during unpredictable versus predictable neutral cues. Credit:Alcohol, Clinical

Updated on: September 05,2024

Brain shows changes in regions associated with anxiety after quitting alcohol, finds study

byResearch Society on AlcoholismGroup × anxiety and group × sex interactions in BNST functional connectivity during unpredictable versus predictable neutral cues. Credit:Alcohol, Clinical

Updated on:September 05,2024